GE HealthCare Technologies Inc Common Stock GEHC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GEHC is a good fit for your portfolio.
News
-
GE HealthCare’s MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes
-
GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women’s Health Imaging
-
RSNA and GE HealthCare Bring Advanced Mammography Technology to Tanzania to Improve Access and Help Address Breast Cancer Mortality Rate
-
GE HealthCare to feature Mobile Mammography Screening Truck along with Latest AI Platform as part of SBI2024 Breast Cancer Imaging Showcase
-
GE HealthCare to Announce First Quarter 2024 Results on April 30, 2024
-
GE HealthCare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images
-
GE Vernova debuts on NYSE, as spinoff from GE's aerospace-only unit completes
-
GE HealthCare closes MIM Software acquisition, bolstering its portfolio and advancing its precision care strategy
Trading Information
- Previous Close Price
- $85.95
- Day Range
- $85.16–86.90
- 52-Week Range
- $62.35–94.50
- Bid/Ask
- $86.01 / $86.75
- Market Cap
- $39.35 Bil
- Volume/Avg
- 1.8 Mil / 3.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 21.83
- Price/Sales
- 2.02
- Dividend Yield (Trailing)
- 0.14%
- Dividend Yield (Forward)
- 0.14%
- Total Yield
- 0.14%
Company Profile
GE HealthCare Technologies Inc is a globally medical technology, pharmaceutical diagnostics, and digital solutions innovator company. It has four operating segments; Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). It earns a majority of its revenue from the Imaging segment.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Mid Core
- Total Number of Employees
- 51,000
- Website
- https://www.gehealthcare.com
Comparables
Valuation
|
Metric
|
GEHC
|
NVST
|
BDX
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.83 | 13.25 | 19.43 |
Price/Book Value | 5.51 | 0.83 | 2.64 |
Price/Sales | 2.02 | 1.32 | 3.44 |
Price/Cash Flow | 17.70 | 8.81 | 20.60 |
Price/Earnings
GEHC
NVST
BDX
Financial Strength
|
Metric
|
GEHC
|
NVST
|
BDX
|
|---|---|---|---|
Quick Ratio | 0.75 | 1.73 | 0.46 |
Current Ratio | 1.05 | 2.23 | 1.08 |
Interest Coverage | 5.31 | 0.13 | 4.17 |
Quick Ratio
GEHC
NVST
BDX
Profitability
|
Metric
|
GEHC
|
NVST
|
BDX
|
|---|---|---|---|
Return on Assets (Normalized) | 5.71% | 4.07% | 3.40% |
Return on Equity (Normalized) | 24.02% | 6.33% | 7.05% |
Return on Invested Capital (Normalized) | 12.32% | 5.48% | 5.04% |
Return on Assets
GEHC
NVST
BDX
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
VEEV
| Veeva Systems Inc Class A | Vrtvjmfwxl | Vcztj | $32.4 Bil | |
SOLV
| Solventum Corp | — | Vkzgnk | $11.1 Bil | |
MTHRF
| M3 Inc | — | Dxlkwd | $8.2 Bil | |
MTHRY
| M3 Inc ADR | — | Cpvjxb | $8.2 Bil | |
PMCUF
| Pro Medicus Ltd | — | Btmvqj | $7.5 Bil | |
HQY
| HealthEquity Inc | — | Tvghbr | $6.8 Bil | |
RCM
| R1 RCM Inc | — | Bght | $5.0 Bil | |
DOCS
| Doximity Inc Class A | — | Tvblvz | $4.4 Bil | |
EVH
| Evolent Health Inc Class A | — | Nzc | $3.3 Bil |